Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia.

El-Khazragy N, Ghozy S, Matbouly S, Zaki W, Safwat G, Hussien G, Khalifa O.

J Cell Biochem. 2019 Apr 30. doi: 10.1002/jcb.28796. [Epub ahead of print]

PMID:
31038787
2.

The prognostic significance of the long non-coding RNAs "CCAT1, PVT1" in t(8;21) associated Acute Myeloid Leukemia.

El-Khazragy N, Elayat W, Matbouly S, Seliman S, Sami A, Safwat G, Diab A.

Gene. 2019 Jul 30;707:172-177. doi: 10.1016/j.gene.2019.03.055. Epub 2019 Mar 31.

PMID:
30943439
3.

IL-28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients.

El-Khazragy N, El Sayed N, Salem AM, Hassan NS, Abdelmoeaz AT, Maher AM, Mansy AE.

J Cell Biochem. 2018 Nov 18. doi: 10.1002/jcb.28096. [Epub ahead of print]

PMID:
30450628
4.

Evaluation of Osteopontin and Pokémon genes expression in hepatitis C virus-associated hepatocellular carcinoma.

El-Khazragy N, Khalifa MM, Salem AM, Swellam M, Hegazy M.

J Cell Biochem. 2018 Nov 11. doi: 10.1002/jcb.28018. [Epub ahead of print]

PMID:
30417409
5.

Dysregulation of miR-125b predicts poor response to therapy in pediatric acute lymphoblastic leukemia.

El-Khazragy N, Elshimy AA, Hassan SS, Matbouly S, Safwat G, Zannoun M, Riad RA.

J Cell Biochem. 2018 Nov 2. doi: 10.1002/jcb.28017. [Epub ahead of print]

PMID:
30390332
6.

miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.

El-Khazragy N, Noshi MA, Abdel-Malak C, Zahran RF, Swellam M.

J Cell Biochem. 2019 Apr;120(4):6315-6321. doi: 10.1002/jcb.27918. Epub 2018 Oct 25.

PMID:
30362157
7.

Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma.

Matboli M, Shafei AE, Ali MA, Gaber AI, Galal A, Tarek O, Marei M, Khairy E, El-Khazragy N, Anber N, Abdel-Rahman O.

J Cell Biochem. 2019 Mar;120(3):3203-3211. doi: 10.1002/jcb.27586. Epub 2018 Oct 26.

PMID:
30362153
8.

Role of some circulating MiRNAs on breast cancer diagnosis.

Swellam M, Zahran RFK, Abo El-Sadat Taha H, El-Khazragy N, Abdel-Malak C.

Arch Physiol Biochem. 2018 Jun 20:1-9. doi: 10.1080/13813455.2018.1482355. [Epub ahead of print]

PMID:
29925280
9.

Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma.

Ali MA, Matboli M, El-Khazragy N, Saber O, El-Nakeep S, Abdelzaher HM, Shafei AE, Mostafa R.

Biomark Med. 2018 Mar;12(3):245-256. doi: 10.2217/bmm-2017-0273. Epub 2018 Feb 14.

PMID:
29441798
10.

Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.

Matboli M, Shafei AE, Azazy AE, Reda M, El-Khazragy N, Nagy AA, Ali MA, Sobhi M, Abdel-Rahman O.

Biomark Med. 2018 Feb;12(2):129-139. doi: 10.2217/bmm-2017-0224. Epub 2018 Jan 17.

PMID:
29338319
11.

Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.

El-Tawdi AH, Matboli M, Shehata HH, Tash F, El-Khazragy N, Azazy Ael-S, Abdel-Rahman O.

Mol Diagn Ther. 2016 Jun;20(3):265-77. doi: 10.1007/s40291-016-0200-9.

PMID:
27113935
12.

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia.

Swellam M, El-Khazragy N.

Tumour Biol. 2016 Aug;37(8):10571-6. doi: 10.1007/s13277-016-4948-7. Epub 2016 Feb 9.

PMID:
26857279

Supplemental Content

Loading ...
Support Center